Literature DB >> 17009909

Rapid antigen detection testing in diagnosing group A beta-hemolytic streptococcal pharyngitis.

Alexander K C Leung1, Rachel Newman, Ashir Kumar, H Dele Davies.   

Abstract

Group A beta-hemolytic streptococcus (GABHS) is the most common bacterial cause of acute pharyngitis. Clinical criteria alone are not reliable enough to diagnose GABHS pharyngitis. Microbiological-testing is required for correct diagnosis. Although a throat swab culture remains the gold standard for documenting the presence of GABHS, a significant disadvantage of the culture is the delayed time of 1-2 days to obtain results. Most rapid antigen detection tests can provide results in less than 15 min. Rapid identification and treatment of patients with GABHS pharyngitis can reduce the risk of the spread of disease, may shorten the duration of symptoms, decrease the incidence of suppurative complications, decrease the amount of time lost from school/work, decrease the inappropriate use of antibiotics, reduce patient/parent dissatisfaction and alleviate the need for costly follow-up visits. All rapid antigen detection tests involve extraction of the group-specific carbohydrate antigen from the GABHS cell wall and identification of the antigen by an immunological reaction. There are numerous rapid antigen detection testing methods, namely latex agglutination, enzyme immunoassay, optical immunoassay, chemiluminescent DNA probes and PCR methods. Most of the rapid antigen detection tests that are currently in use have an excellent specificity of greater than 95% and a sensitivity of greater than or equal to 90%. Owing to the high specificity of the rapid antigen detection tests, a positive rapid antigen detection test is accepted as adequate for the diagnosis of GABHS pharyngitis. Conversely, confirmation of a negative antigen detection test with a throat culture result is necessary, unless the physician has ascertained in his/her practice that the sensitivity of the rapid antigen test used is comparable with that of a throat culture.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17009909     DOI: 10.1586/14737159.6.5.761

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  16 in total

Review 1.  Better tests, better care: improved diagnostics for infectious diseases.

Authors:  Angela M Caliendo; David N Gilbert; Christine C Ginocchio; Kimberly E Hanson; Larissa May; Thomas C Quinn; Fred C Tenover; David Alland; Anne J Blaschke; Robert A Bonomo; Karen C Carroll; Mary Jane Ferraro; Lisa R Hirschhorn; W Patrick Joseph; Tobi Karchmer; Ann T MacIntyre; L Barth Reller; Audrey F Jackson
Journal:  Clin Infect Dis       Date:  2013-12       Impact factor: 9.079

Review 2.  Group A Streptococcus Testing in Pediatrics: the Move to Point-of-Care Molecular Testing.

Authors:  Thomas Z Thompson; Allison R McMullen
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

Review 3.  Erythema nodosum.

Authors:  Alexander K C Leung; Kin Fon Leong; Joseph M Lam
Journal:  World J Pediatr       Date:  2018-09-29       Impact factor: 2.764

4.  Molecular and clinical diagnosis of group A streptococcal pharyngitis in children.

Authors:  Susanna Felsenstein; Diala Faddoul; Richard Sposto; Kristine Batoon; Claudia M Polanco; Jennifer Dien Bard
Journal:  J Clin Microbiol       Date:  2014-08-20       Impact factor: 5.948

5.  Narrow-Spectrum Antibacterial Agents.

Authors:  Roberta J Melander; Daniel V Zurawski; Christian Melander
Journal:  Medchemcomm       Date:  2017-11-06       Impact factor: 3.597

6.  Targeted Treatment for Bacterial Infections: Prospects for Pathogen-Specific Antibiotics Coupled with Rapid Diagnostics.

Authors:  Tucker Maxson; Douglas A Mitchell
Journal:  Tetrahedron       Date:  2015-10-09       Impact factor: 2.457

7.  Immunoasssay chromatographic antigen test for rapid diagnosis of Group A beta hemolytic Streptococcus pharyngitis in children: A cross/ sectional study.

Authors:  S Noorbakhsh; A Tabatabaei; M Farhadi; Taj F Ebrahimi
Journal:  Iran J Microbiol       Date:  2011-06

Review 8.  Rheumatic heart disease in Africa: is there a role for genetic studies?

Authors:  Ana Olga Mocumbi
Journal:  Cardiovasc J Afr       Date:  2015 Mar-Apr       Impact factor: 1.167

Review 9.  Can we prevent antimicrobial resistance by using antimicrobials better?

Authors:  Germander Soothill; Yanmin Hu; Anthony Coates
Journal:  Pathogens       Date:  2013-06-10

10.  Managing severe infection in infancy in resource poor settings.

Authors:  Anna C Seale; James A Berkley
Journal:  Early Hum Dev       Date:  2012-09-30       Impact factor: 2.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.